Skip to main content

Table 2 Drug treatment schedules and doses

From: Longitudinal study of Plasmodium falciparum and Plasmodium vivax in a Karen population in Thailand

(a) P. falciparum

Patient group

Mefloquine (250 mg tablet)

Primaquine (mg)

        

< 1 year

1/2

-

        

1–3 years

3/4

5

        

4–8 years

1 1/2

10

        

9–14 years

2

15

        

15+ years

3

30

        

(b) P. vivax

Patient group

Day 1

Day 2

Day 3

Day 4

 

C*

C*

C*

P+

C*

P+

C*

P+

C*

P+

< 6 m

1/2

-

-

-

1/2

-

-

-

-

-

6–11 m

1

-

-

-

1/2

1

1/2

-

-

-

1–3 y

1

1

-

2.5

1

2.5

1

2.5

1

2.5

4–8 y

1

1

1

5

1

5

1

5

1

5

9–14 y

2

2

-

10

1

10

1

10

1

10

15+y

2

2

2

15

2

15

2

15

2

15

  1. m – months; y – years; C – chloroquine phosphate (250 mg); P – primaquine; * - tablet; + - mg